John K. Westwick

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA.

Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA.

Resonant Therapeutics, Inc. operates as a life science company that focuses on generating novel targets relevant to in vivo tumor biology with unprecedented speed. The company was founded by John K. Westwick and Stephen J. Weiss in 2014 and is headquartered in Houston, TX.

Courier Therapeutics, Inc. is a company based in Houston, TX. Courier Therapeutics, Inc. specializes in courier therapeutics. The company was founded by Dan M. Watkins, who has been the CEO since incorporation. Courier Therapeutics was acquired by Valo Health LLC on July 27, 2021.